Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.76 |
| ▸ | ADH1B | P00325 | 1/20 | 0.37 |
| ▸ | ADH1C | P00326 | 1/20 | 0.37 |
| ▸ | ADH1A | P07327 | 1/20 | 0.37 |
| ▸ | ADH4 | P08319 | 1/20 | 0.37 |
| ▸ | ADH7 | P40394 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
| ▸ | GAPDH | P04406 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.30 |
| ▸ | FDPS | P14324 | 3/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811957 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL12047 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL2925112 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL3842154 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL1301414 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL2922631 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL1301118 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL3851169 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL1300982 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL28633919 | 0.93 | TSHR (0.82) | TSHRSMN1; SMN2ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11725288-B2 | Corrosion inhibition package | DORF KETAL CHEMICALS FZE (AE) | 2023-08-15 | — | — | US | claimed |
| US-20200224097-A1 | Corrosion Inhibition Package | HSBC BANK MIDDLE EAST LIMITED (AE) | 2020-07-16 | — | — | US | claimed |
| WO-2020124195-A1 | CORROSION INHIBITION PACKAGE COMPRISING A DIALDEHYDE-CONTAINING HYDROCARBON | FLUID ENERGY GROUP LTD. (CA) | 2020-06-25 | — | — | WO | claimed |
| EP-3670631-A1 | NOVEL CORROSION INHIBITION PACKAGE | Fluid Energy Group Ltd (CA) | 2020-06-24 | — | — | EP | claimed |
| US-9738617-B2 | Methods for producing fuels, gasoline additives, and lubricants | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-22 | — | — | US | disclosed |
| US-9738617-B2 | Methods for producing fuels, gasoline additives, and lubricants | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-22 | — | — | US | disclosed |
| US-20160115143-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-04-28 | — | — | US | disclosed |
| US-20160115143-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115143-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS | DGAT1, DGAT2, GK | TSHR 4663/4885SMN1; SMN2 2291/4885ADH1B 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.